Literature DB >> 17156762

Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites.

Ezzat Hashemi1, Peyman Sahbaie, M Frances Davies, J David Clark, Timothy M DeLorey.   

Abstract

Gabrb3 gene deficient (gabrb3(-/-)) mice, control littermates (gabrb3(+/+)) and their progenitor strains C57Bl/6J and 129/SvJ were assessed for changes in the morphology of the main noradrenergic nuclei, the locus coeruleus (LC) and LC-associated behaviors including anxiety and muscle tone. While the area defined by the cell bodies of the LC was found not to differ between gabrb3(-/-) mice and controls, the pericoerulear dendritic zone of the LC was found to be significantly enlarged in gabrb3(-/-) mice. Relative to controls, gabrb3(-/-) mice were also found to be hypotonic, as was indicated by poor performance on the wire hanging task. Gabrb3(-/-) mice also exhibited a significant increase in stretch-attend posturing, a form of risk assessment behavior associated with anxiety. However, in the plus maze, a commonly used behavioral test for assessing anxiety, no significant difference was observed between gabrb3(-/-) and control mice. Lastly, relative to controls, gabrb3(-/-) mice exhibited significantly less marble burying behavior, a method commonly used to assess obsessive-compulsive behavior. However, the poor marble burying performance of the gabrb3(-/-) mice could be associated with the hypotonic condition exhibited by these mice. In conclusion, the results of this study indicate that the gabrb3 gene contributes to LC noradrenergic dendrite development with the disruption of this gene in mice resulting in an enlarged plexus of LC dendrites with a concurrent reduction in muscle tone and marble burying behavior, an increase in risk assessment behavior but no change in the plus maze parameters that are commonly used for assessing anxiety.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156762      PMCID: PMC1894748          DOI: 10.1016/j.brainres.2006.10.050

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  69 in total

1.  Mouse models for autism: report from a meeting.

Authors:  T R Insel
Journal:  Mamm Genome       Date:  2001-10       Impact factor: 2.957

Review 2.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance.

Authors:  Gary Aston-Jones; Jonathan D Cohen
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

3.  Enhancement of GABA-dependent chloride channel by "in vivo" administration of ethanol.

Authors:  E Sanna; A Concas; M Serra; G Biggio
Journal:  Pharmacol Res       Date:  1990 Sep-Oct       Impact factor: 7.658

4.  Behavioral abnormalities of Zic1 and Zic2 mutant mice: implications as models for human neurological disorders.

Authors:  H Ogura; J Aruga; K Mikoshiba
Journal:  Behav Genet       Date:  2001-05       Impact factor: 2.805

5.  Association between a GABRB3 polymorphism and autism.

Authors:  J D Buxbaum; J M Silverman; C J Smith; D A Greenberg; M Kilifarski; J Reichert; E H Cook; Y Fang; C-Y Song; R Vitale
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder.

Authors:  A Woods-Kettelberger; S Kongsamut; C P Smith; J T Winslow; R Corbett
Journal:  Expert Opin Investig Drugs       Date:  1997-10       Impact factor: 6.206

7.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes.

Authors:  Yujun Shao; M L Cuccaro; E R Hauser; K L Raiford; M M Menold; C M Wolpert; S A Ravan; L Elston; K Decena; S L Donnelly; R K Abramson; H H Wright; G R DeLong; J R Gilbert; M A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2003-02-03       Impact factor: 11.025

9.  Enhancement of current induced by superfusion of GABA in locus coeruleus neurons by pentobarbital, but not ethanol.

Authors:  S S Osmanović; S A Shefner
Journal:  Brain Res       Date:  1990-05-28       Impact factor: 3.252

10.  5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice.

Authors:  Y Ichimaru; T Egawa; A Sawa
Journal:  Jpn J Pharmacol       Date:  1995-05
View more
  10 in total

Review 1.  Autism, fever, epigenetics and the locus coeruleus.

Authors:  Mark F Mehler; Dominick P Purpura
Journal:  Brain Res Rev       Date:  2008-11-24

2.  Nr2f1 heterozygous knockout mice recapitulate neurological phenotypes of Bosch-Boonstra-Schaaf optic atrophy syndrome and show impaired hippocampal synaptic plasticity.

Authors:  Chun-An Chen; Wei Wang; Steen E Pedersen; Ayush Raman; Michelle L Seymour; Fernanda R Ruiz; Anping Xia; Meike E van der Heijden; Li Wang; Jiani Yin; Joanna Lopez; Megan E Rech; Richard A Lewis; Samuel M Wu; Zhandong Liu; Fred A Pereira; Robia G Pautler; Huda Y Zoghbi; Christian P Schaaf
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

3.  Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3.

Authors:  Timothy M DeLorey; Peyman Sahbaie; Ezzat Hashemi; Wen-Wu Li; Ahmad Salehi; David J Clark
Journal:  Behav Brain Res       Date:  2010-08-10       Impact factor: 3.332

4.  Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder.

Authors:  Timothy M DeLorey; Peyman Sahbaie; Ezzat Hashemi; Gregg E Homanics; J David Clark
Journal:  Behav Brain Res       Date:  2007-09-14       Impact factor: 3.332

Review 5.  The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13.

Authors:  Amber Hogart; David Wu; Janine M LaSalle; N Carolyn Schanen
Journal:  Neurobiol Dis       Date:  2008-09-18       Impact factor: 5.996

Review 6.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

7.  The neurobiology of mouse models syntenic to human chromosome 15q.

Authors:  Toru Takumi
Journal:  J Neurodev Disord       Date:  2011-07-26       Impact factor: 4.025

8.  Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation.

Authors:  Megan K Mulligan; Xusheng Wang; Adrienne L Adler; Khyobeni Mozhui; Lu Lu; Robert W Williams
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

9.  Deletion of PREPl causes growth impairment and hypotonia in mice.

Authors:  Anna Mari Lone; Mathias Leidl; Amanda K McFedries; James W Horner; John Creemers; Alan Saghatelian
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Age-Dependent Changes in the Inflammatory Nociceptive Behavior of Mice.

Authors:  Tanya S King-Himmelreich; Christine V Möser; Miriam C Wolters; Katrin Olbrich; Gerd Geisslinger; Ellen Niederberger
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.